As was evident in this study, inhibiting the p38-ATF2 pathway reversed the unfavorable outcomes of noxin on breast cancer cells, which may provide great insight into the development of new drugs that alter the outcomes of breast cancer. The gene discussed is DDIAS; the disease is breast cancer.